Boston Scientific CorporationBSXNYSE
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$2.63B
↑ 63% above average
Average (9y)
$1.62B
Historical baseline
Range
High:$2.63B
Low:$601.00M
CAGR
+14.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.63B | +20.8% |
| 2023 | $2.18B | +19.6% |
| 2022 | $1.82B | -5.1% |
| 2021 | $1.92B | +219.8% |
| 2020 | $601.00M | -64.9% |
| 2019 | $1.71B | -1.4% |
| 2018 | $1.74B | +13.9% |
| 2017 | $1.52B | +23.4% |
| 2016 | $1.24B | +56.5% |
| 2015 | $790.00M | - |